Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Symphony board member invests on another quiet day

(Sharecast News) - It was a very quiet day for director deals on Tuesday, with Symphony International finding itself at the top of a short list of buys. The London-listed firm said director Anil Thadani bought 76,120 shares on the open market on Thursday, at a price of 46 US cents each.

That valued the transaction at $34,939.08 (£26,883).

As well as being a board director of Symphony International, Thadani is chairman of both its investment manager Symphony Investment Managers, and of Symphony Asia Holdings.

Elsewhere, Aberforth Split Level Income Trust disclosed a director purchase worth almost £20k.

The company said director Graeme Bissett bought 84,404 shares on Thursday at a price of 75.01p each, valuing the transaction at £19,899.24.

There were no transactions to note on the selling side of the ledger as of Tuesday afternoon.

Top Director Buys

Symphony International Holdings Ltd. (SIHL) Director name: Thadani,Anil Amount purchased: 76,120 @ $0.46 Value: $34,939.08

Aberforth Split Level Income Trust (ASIT) Director name: Bissett,Graeme Amount purchased: 26,528 @ 75.01p Value: £19,899.24

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.